Jubilant Cadista Recalls Valsartan Tablets Due to Incorrect Excipient Grade
Jubilant Cadista Pharmaceuticals is recalling 7,048 bottles of Valsartan 320 mg tablets because an incorrect grade of excipient may have been used during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which typically corresponds to a score of 1 or 2. Given the potential for an incorrect excipient grade, a score of 2 (Moderate) is appropriate as it represents a low-risk contamination or labeling issue that is unlikely to cause adverse health consequences.
Plain-English summary
Jubilant Cadista Pharmaceuticals, Inc. is recalling 7,048 bottles of Valsartan Tablets USP, 320 mg, 90-count. The recall involves specific lots with expiration dates of 09/2019 and 10/2019. The product is a prescription-only medication manufactured by Jubilant Generics Ltd in India and marketed by Jubilant Cadista Pharmaceuticals in Salisbury, MD.
The recall was initiated because there is a potential that an incorrect grade of excipient was used during the manufacturing process. The affected product was distributed throughout the United States to wholesalers and retailers.
Consumers who have this medication should contact their healthcare provider or pharmacist for guidance on how to proceed. The recall is classified as Class III by the FDA, indicating that the use of or exposure to the product is not likely to cause adverse health consequences.
The recalled product
- Product
- VALSARTAN (VALSARTAN)
- Brand
- VALSARTAN
- Manufacturer
- Jubilant Cadista Pharmaceuticals, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 7,048
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: VR417062A
- Exp. 09/2019
- VR417063A
- VR417064A
- Exp. 10/2019
UPCs (8)
- 0359746363321
- 0359746363307
- 0359746361037
- 0359746362034
- 0359746360306
- 0359746360030
- 0359746361303
- 0359746362300
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 4 recalled by Jubilant Cadista Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · VALSARTAN
- ModerateCardinal Health Recalls Valsartan Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SevereAurobindo Pharma Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereAurobindo Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereAurobindo Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereAurobindo Pharma Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
Same manufacturer · Jubilant Cadista Pharmaceuticals, Inc.
See all →- Moderate
- HighIrbesartan Blood Pressure Tablets Recalled Due to Failed Dissolution
FDA (Drugs) · 2022-08-03
- HighJubilant Cadista Irbesartan tablets recalled due to failed dissolution
FDA (Drugs) · 2022-08-03
- ModerateFDA Voluntary Recall of Methylprednisolone Tablets for Subpotency
FDA (Drugs) · 2022-04-13
- SevereMeclizine Hydrochloride Tablets Recalled Due to Incorrect Label Mix-up
FDA (Drugs) · 2022-04-06
Same hazard · incorrect excipient
See all →- ModerateTadalafil Tablets Recalled for Incorrect Product Formulation
FDA (Drugs) · 2021-11-17
- ModerateQuVa Pharma Recalls Norepinephrine Injection Bags Due to Incorrect Excipient
FDA (Drugs) · 2018-12-19
- LowJubilant Cadista Recalls Valsartan Tablets Due to Potential Excipient Error
FDA (Drugs) · 2018-08-29
- LowJubilant Cadista Recalls Valsartan Tablets Due to Incorrect Excipient Grade
FDA (Drugs) · 2018-08-29
- LowJubilant Cadista Recalls Valsartan Tablets Due to Incorrect Excipient Size
FDA (Drugs) · 2018-06-13